Target Choice and Exon Skipping Regulate CRISPR-Directed Gene Editing of NRF2 in Head/Neck and Esophageal Cancer Cells

Investigators disabled specific endpoints of NRF2 in an attempt to restore chemo-sensitivity in head/neck and esophageal cancer cells. They identified two targeting characteristics that regulate the effectiveness of this approach.